$96.00
0.12[0.13%]
At close: Mar 28
$96.00
0[0.00%]
After Hours: 4:09PM EDT
Novartis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novartis using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/23/2024 | AM | NVS | Q1 | $1.71 | $1.69 | — | — | $12.95B | $11.48B | — | — | Get Alert |
01/31/2024 | AM | NVS | Q4 | $1.52 | $1.68 | $1.53 | -8.93% | $12.69B | $11.56B | $11.42B | -1.19% | Get Alert |
10/24/2023 | AM | NVS | Q3 | $1.58 | $1.70 | $1.74 | — | $12.54B | $11.40B | $11.78B | 3.35% | Get Alert |
07/18/2023 | AM | NVS | Q2 | $1.56 | $1.66 | $1.83 | — | $12.78B | $13.17B | $13.62B | 3.42% | Get Alert |
04/25/2023 | AM | NVS | Q1 | $1.46 | $1.55 | $1.71 | 10.32% | $12.53B | $12.64B | $12.95B | 2.48% | Get Alert |
02/01/2023 | AM | NVS | Q4 | $1.40 | $1.44 | $1.52 | 5.56% | $13.23B | $13.13B | $12.69B | -3.35% | Get Alert |
10/25/2022 | AM | NVS | Q3 | $1.71 | $1.57 | $1.58 | 0.64% | $13.03B | $12.99B | $12.54B | -3.44% | Get Alert |
07/19/2022 | AM | NVS | Q2 | $1.66 | $1.52 | $1.56 | 2.63% | $12.96B | $13.01B | $12.78B | -1.76% | Get Alert |
04/26/2022 | AM | NVS | Q1 | $1.52 | $1.44 | $1.46 | 1.39% | $12.41B | $12.73B | $12.53B | -1.56% | Get Alert |
02/02/2022 | AM | NVS | Q4 | $1.34 | $1.42 | $1.40 | -1.41% | $12.77B | $13.30B | $13.23B | -0.53% | Get Alert |
10/26/2021 | AM | NVS | Q3 | $1.52 | $1.65 | $1.71 | 3.64% | $12.26B | $13.03B | $13.03B | 0.00% | Get Alert |
07/21/2021 | AM | NVS | Q2 | $1.36 | $1.52 | $1.66 | 9.21% | $11.35B | $12.51B | $12.96B | 3.57% | Get Alert |
04/27/2021 | AM | NVS | Q1 | $1.56 | $1.59 | $1.52 | -4.40% | $12.28B | $12.51B | $12.41B | -0.79% | Get Alert |
01/26/2021 | AM | NVS | Q4 | $1.32 | $1.36 | $1.34 | -1.47% | $12.40B | $12.87B | $12.77B | -0.78% | Get Alert |
10/27/2020 | AM | NVS | Q3 | $1.41 | $1.45 | $1.52 | 4.83% | $12.17B | $12.53B | $12.26B | -2.16% | Get Alert |
07/21/2020 | AM | NVS | Q2 | $1.34 | $1.35 | $1.36 | 0.74% | $11.76B | $12.00B | $11.35B | -5.44% | Get Alert |
04/28/2020 | AM | NVS | Q1 | $1.21 | $1.36 | $1.56 | 14.71% | $11.11B | $12.03B | $12.28B | 2.10% | Get Alert |
01/29/2020 | AM | NVS | Q4 | $1.25 | $1.25 | $1.32 | 5.60% | $13.27B | $12.12B | $12.40B | 2.33% | Get Alert |
10/22/2019 | AM | NVS | Q3 | $1.32 | $1.34 | $1.41 | 5.22% | $12.78B | $11.69B | $12.17B | 4.12% | Get Alert |
Novartis (NVS) is scheduled to report earnings on April 23, 2024. The last reported earnings were for reported on January 31, 2024 for Q4.
The Actual EPS was $1.53, which missed the estimate of $1.68.
The Actual Revenue was $11.4B, which missed the estimate of $11.6B.
Browse earnings estimates, EPS, and revenue on all stocks.